CTS
CTS Corporation
CTS has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over CTS overall, supported by stronger fundamentals and stronger modeled upside.
CTS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Strong |
CTS's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
CTS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $61.01 | — |
| Cheap | 22x | $54.94 | -10% |
| Current | 24x | $61.01 | — |
| Fair | 25x | $62.16 | +1.9% |
| Expensive | 29x | $73.78 | +21% |
Historical ranges are pointers, not guarantees.
CTS's PE is in its fair range at 24x. If earnings grow as analysts expect, today's price would be 21x next year's earnings, in its cheap range.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over CTS in the historical PE scenario, which offers more potential upside but is not a forecast.
CTS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CTS, with profitability improving.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
CTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.85 | +13% |
| Q3 2026 | $2.53 | +29% |
| Q2 2026 | $2.38 | +13% |
| Q1 2026 | $2.34 | +19% |
| Q4 2025 | $2.19 | +16% |
| Q3 2025 | $1.96 | +1% |
| Q2 2025 | $2.11 | +19% |
| Q1 2025 | $1.97 | +16% |
| Q4 2024 | $1.89 | -1.6% |
CTS earned $2.53 per share over the past year, up 29% from the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over CTS in the latest year-over-year earnings comparison.
CTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $149.6M | +4.6% |
| Q2 2026 | $144.8M | +7% |
| Q1 2026 | $139.2M | +11% |
| Q4 2025 | $137.3M | +7.7% |
| Q3 2025 | $143M | +8% |
| Q2 2025 | $135.3M | +4% |
| Q1 2025 | $125.8M | 0% |
| Q4 2024 | $127.4M | +2.2% |
CTS's revenue has grown year over year for eight quarters in a row: $150M last quarter, up 4.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +2.4 points |
| Q2 2026 | 19% | +1.7 points |
| Q1 2026 | 16% | +2.8 points |
| Q4 2025 | 17% | +1.6 points |
| Q3 2025 | 15% | -1.6 points |
| Q2 2025 | 17% | +3.2 points |
| Q1 2025 | 13% | +1.4 points |
| Q4 2024 | 15% | +1.9 points |
CTS's operating margin was 17% last quarter, up 2.4 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK's revenue has grown year over year for six quarters in a row: $11B last quarter, up 378% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over CTS on profitability, with a higher operating margin.
CTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $41.1M | +70% |
| Q2 2026 | $28.9M | +15% |
| Q1 2026 | $12.3M | +11% |
| Q4 2025 | $26M | +31% |
| Q3 2025 | $24.2M | -23% |
| Q2 2025 | $25.1M | +67% |
| Q1 2025 | $11.1M | -23% |
| Q4 2024 | $19.9M | -31% |
CTS has the edge over SNDK on cash flow, with more consistent year-over-year improvement.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
CTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +8K shares |
| 1 year | -2.4% | -710K shares |
| 3 years | -8.2% | -2.6M shares |
| 5 years | -11% | -3.5M shares |
| Available history | -13% | -4.2M shares |
CTS has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.3M |
| Q2 2026 | $3.4M |
| Q1 2026 | $8.6M |
| Q4 2025 | $16.6M |
| Q3 2025 | $16.6M |
| Q2 2025 | $16.5M |
| Q1 2025 | $6.5M |
| Q4 2024 | $7.8M |
CTS spent $32M buying back its own shares over the past year, down 33% from the year before.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CTS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Net Cash |
| Q4 2024 | -0.0x | Net Cash |
CTS has the edge over SNDK on leverage, with a lower net debt burden relative to earnings.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
CTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.0 | Neutral |
| Stochastic | 49.7 | Neutral |
CTS's weekly RSI is 54 (neutral) and its Stochastic is 50 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
CTS PE vs Technology Sector
| Metric | CTS | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 28x | 13% below |
| PE % | 43 | 35 | 8 pts above |
CTS is trading at 24x earnings, a 13% discount to the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over CTS on valuation relative to its sector.
CTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $58.3 | 4.6% above |
| 20 week MA | $59.4 | 2.7% above |
| 50 week MA | $55.8 | 9.3% above |
| 100 week MA | $49.4 | 24% above |
| 200 week MA | $47.6 | 28% above |
CTS has stronger trend alignment. CTS is above 5 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
CTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.6 | $33.7 | +14% |
| 2021 | $33.7 | $36.3 | +7.8% |
| 2022 | $36.3 | $38.9 | +7.1% |
| 2023 | $38.9 | $43.7 | +12% |
| 2024 | $43.7 | $53.1 | +21% |
| 2025 | $53.1 | $44.5 | -16% |
| 2026 YTD | $44.5 | $61.0 | +37% |
CTS has finished higher in five of the last six years. It's up 37% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over CTS on returns for 2026, with the stronger performance.